Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: NTRA) | Delayed: 403.12 +1.75 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $401.37 | 52 Week High | $13.80 | |||
| Open | $399.95 | 52 Week Low | $6.52 | |||
| Day High | $408.28 | P/E | N/A | |||
| Day Low | $395.33 | EPS | $0.00 | |||
| Volume | 209,897 | |||||
